| Affiliation: | 1. Department of Radiation Oncology (MAASTRO Clinic), GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands;2. Department of Oncology, Experimental Radiation Oncology, KU Leuven, Leuven, Belgium;3. Department of Biostatistics and Epidemiology and “Ligue Nationale Contre le Cancer” meta-analysis platform, Gustave Roussy, Villejuif, France;4. CESP, INSERM U1018, Université Paris-Sud, Université Paris-Saclay, Villejuif;5. Department of Oncology and radiation therapy, Gustave Roussy, Villejuif;6. Université Paris-Sud, Université Paris-Saclay, Villejuif, France;7. UT Southwestern University School of Medicine, Dallas, USA;8. EORTC Data Center, Brussels, Belgium;9. British Columbia Cancer Agency, Vancouver, Canada;10. University College London Hospitals, London, UK;11. Alliance Data and Statistical Center, Duke University, Durham, USA;12. Osaka Prefectural Habikino Hospital, Osaka, Japan;13. Hôpital St Antoine, Paris, France;14. Wake Forest University School of Medicine, Winston-Salem, USA;15. Second Department of Medical Oncology, Metropolitan Hospital N. Faliro, Athens, Greece;16. The Netherlands Cancer Institute, Amsterdam, The Netherlands;17. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, USA;18. NHS Lothian and University of Edinburgh, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK;19. NCIC Clinical Trials Group and Queen''s University, Kingston, Canada;20. Gustave Roussy, Villejuif, France;21. Karolinska Institutet, Stockholm, Sweden |
